Invention Grant
- Patent Title: Bicyclic peptide-toxin conjugates specific for MT1-MMP
-
Application No.: US16097305Application Date: 2017-05-04
-
Publication No.: US10994019B2Publication Date: 2021-05-04
- Inventor: Daniel Teufel , Silvia Pavan , Leonardo Baldassarre
- Applicant: BicycleRD Limited
- Applicant Address: GB Cambridge
- Assignee: BicycleRD Limited
- Current Assignee: BicycleRD Limited
- Current Assignee Address: GB Cambridge
- Agency: Dechert LLP
- Agent Andrea L.C. Reid; Paul R. Fleming
- Priority: GB1607827 20160504
- International Application: PCT/GB2017/051250 WO 20170504
- International Announcement: WO2017/191460 WO 20171109
- Main IPC: A61K31/5365
- IPC: A61K31/5365 ; A61K47/64 ; C07D265/04 ; C07D265/12 ; C07K7/08 ; C07K14/00 ; A61P35/00
Abstract:
The present invention relates to drug conjugates comprising bicyclic peptides specific for MT1-MMP conjugated to one or more effector and/or functional groups which have utility in targeted cancer therapy.
Public/Granted literature
- US20190134213A1 BICYCLIC PEPTIDE-TOXIN CONJUGATES SPECIFIC FOR MT1-MMP Public/Granted day:2019-05-09
Information query
